Auf Tumorgefässmarker gerichtete Impfstoffe
Patent europeic · EP2568044 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP2568044
- Numer da la dumonda
- EP12183807
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 29-09-2009
- Publitgà
- 13-03-2013
- Concedì
- 08-04-2015
- La protecziun finescha il pli tard
- 28-09-2029
- Proxima taxa annuala scadenta
- 30-09-2027
- Classas IPC
- C12N 15/09 (2006.01)
- Prioritad
- US 101083 P 29.09.2008US 181659 P 27.05.2009
- Derivà da
- EP09817051
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-10-2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- 01-10-2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- 03-10-2024
Midada
Published in Swissreg on 03.10.2024
- 01-10-2023
Midada
Published in Swissreg on 01.10.2023
- 01-10-2022
Midada
Published in Swissreg on 01.10.2022
- 13-08-2015
Represchentant inscrit
- Representative
- Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex
Published in Swissreg on 13.08.2015
- 08-04-2015
Concedì
Published in Swissreg on 08.04.2015
Partidas
Represchentant
Inventur
Wynnewood, PA 19096, US
Teramo 64014, IT
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.